(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
0.32% $ 34.74
Live Chart Being Loaded With Signals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye...
Stats | |
---|---|
Volumen de hoy | 10 000.00 |
Volumen promedio | 469.00 |
Capitalización de mercado | 64.23M |
EPS | $-0.420 ( 2021-11-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -19.65 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-02 | From Stephen | Sell | 250 | Common Stock |
2021-11-02 | Mann Brenda | Sell | 62 | Common Stock |
2021-10-04 | Mann Brenda | Sell | 62 | Common Stock |
2021-10-04 | From Stephen | Sell | 249 | Common Stock |
2021-09-02 | From Stephen | Sell | 253 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 1 959 813 | Sell: 207 057 |
EyeGate Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
BMTC | 0.948 |
XPDI | 0.926 |
FATE | 0.912 |
TCDA | 0.908 |
GRAY | 0.905 |
ENPH | 0.896 |
BCAB | 0.895 |
ODT | 0.887 |
HECCU | 0.884 |
LHDX | 0.879 |
10 Correlaciones Más Negativas | |
---|---|
TIG | -0.936 |
CCRC | -0.928 |
FRGI | -0.917 |
ARNA | -0.903 |
DSPG | -0.899 |
ACIW | -0.899 |
NTES | -0.896 |
EXAS | -0.896 |
APEN | -0.896 |
GGAL | -0.895 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EyeGate Pharmaceuticals Finanzas
Annual | 2020 |
Ingresos: | $12 059.00 |
Beneficio Bruto: | $12.06 (0.10 %) |
EPS: | $-2.54 |
FY | 2020 |
Ingresos: | $12 059.00 |
Beneficio Bruto: | $12.06 (0.10 %) |
EPS: | $-2.54 |
FY | 2019 |
Ingresos: | $2.69M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-2.23 |
FY | 2018 |
Ingresos: | $1.65M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-4.50 |
Financial Reports:
No articles found.
EyeGate Pharmaceuticals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. The company is headquartered in Waltham, Massachusetts and currently employs 11 full-time employees. The firm is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The firm's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The firm is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico